Redwood City, Calif.
Abbott Labs has proposed a 1,000,000-sf expanison in Redwood City, providing manufacturing and R&D facilities for the Chicago-based bioscience company's cardiac products. Maximizing the company's proximity to the world-class cardiac clinics at Sequoia Hospital and Stanford Hospital, Abbot purchased the Redwood City-based Perclose biotech in 1999. Abbott plans to spend up to $350 million on the new complex. Ground may be broken on the three-phase project by the end of 2002.